Esovil L 75mg/40mg Capsule SR is a combination medication containing Levosulpiride 75mg and Esomeprazole 40mg, designed to effectively manage gastrointestinal disorders. Levosulpiride is a prokinetic agent that enhances gastric motility by blocking dopamine receptors, thereby improving symptoms such as nausea, vomiting, bloating, and delayed gastric emptying. Esomeprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the stomach lining, providing relief from acid-related conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis. The sustained-release formulation ensures a gradual and prolonged therapeutic effect, improving patient compliance and symptom control. Esovil L is commonly prescribed for patients suffering from functional dyspepsia, GERD with motility disturbances, and other acid-peptic disorders accompanied by impaired gastric motility. It should be taken as directed by a healthcare professional, usually once daily before meals. Patients should inform their doctor about any existing medical conditions or medications to avoid potential interactions. Common side effects may include headache, dizziness, or mild gastrointestinal discomfort, but serious adverse effects are rare. Overall, Esovil L 75mg/40mg Capsule SR offers a dual-action approach to managing complex gastrointestinal symptoms effectively.